Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587764 · ClinicalTrials.gov registry record
Tempus Pro Monitor Registry
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 103
- Enrollment target
NCT05587764: Completed study, sponsored by Philips Clinical & Medical Affairs Global.
NCT05587764 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05587764 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
A multicenter, prospective and retrospective, observational, post market study.
Primary Outcome
The proportion of 12-lead ECG pairs that are identical, after a cardiologist's review of printouts from Corsium IntelliSpace (transmitted) ECG and the original ECG from the Tempus Pro device.
Interventions
- DIAGNOSTIC_TEST Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2024-08-12 |
What the finished NCT05587764 record still lists
NCT05587764 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Standard of Care is the first listed.
NCT05587764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05587764 about?
NCT05587764 is a clinical study titled "Tempus Pro Monitor Registry". A multicenter, prospective and retrospective, observational, post market study.
What is the current status of trial NCT05587764?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2024-04-25. Estimated completion is 2024-08-12.
What interventions are being tested in trial NCT05587764?
The interventions under investigation include: Standard of Care (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05587764?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI